In view of the lower VEGFR-1 protein levels in the early-onset preeclampsia group as compared to the control and the higher severity of angiogenic/anti-angiogenic imbalance [36], it is not surprising that maternal supplementation of omega-3 fatty acids fails to work for women with early-onset preeclampsia. This evidence concerns the gene FLT1 and preeclampsia.